RE: Share Price21 May 2024 23:19
Personally, I don't see why the June update is make or break for CPI. It's AH's first opportunity to lay down what the cost cuts will look like. He should be in a position to quantify the volume of savings and indicative EBITDA margins from 2024 onwards assuming a flat revenue profile this year.
The first actual set of profitability numbers will come from the H1 results in August and that will the first of many data points to show progress or otherwise for CPI - that is key for the market, not next month's update.
For all those who focused on the fact that they didn't expect a revenue decline in the stated first 4 months of 2024 - I really don't know what you smoke when you read up financial reports. Here's a snippet from the March earnings results release with the stars indicating their statement about revenues accruing later in the year.
"For 2024, as a whole, on an adjusted basis, we currently expect that revenue will be broadly in line with 2023, and that operating profit margin and free cash flow will show modest improvement year on year.
We expect the ***** Public Service division to deliver revenue growth in 2024 reflecting the significant contracts won in 2023 moving into their operational phase later this year ***** whereas we expect the Experience division to show a reduction in revenue reflecting the non-recurrence of 2023’s closed book Life & Pensions commercial settlement coupled with ongoing revenue attrition in the rest of the Life & Pensions business.
Notwithstanding our revenue expectations, the cost reduction programmes being implemented in 2024 are expected to result in a modest improvement in adjusted operating profit margins and free cash flow, albeit in the latter case, the cash flow benefit in the year will be reduced as a result of the redundancy and other costs required to deliver the cost reduction programmes.
We will be setting out our vision, strategy and associated medium-term targets in detail at a Capital Markets Day in June 2024."
None of what was announced today was different from what was stated in March - additional clarity was provided and the upswing in revenue will accrue in H2. This is still transition year, but I'd expect the market to pay attention and start to slowly rerate the share over the course of the remainder of the year, post the update.
The stock market is a great mechanism to transfer wealth from the impatient to the patient....